Fedha

Hisa unazofuatilia
1177:HKG
Sino Biopharmaceutical Ltd
HK$ 5.25
-0.38%
(-0.020) Siku 1
16 Okt, 16:08:14 GMT +8  ·   HKD
Alama zote
AlamaBeiTofautiTofauti ya asilimia
Inatayarisha maarifa maarufu ya 1177...
Fungua
HK$ 5.40
Juu
HK$ 5.50
Chini
HK$ 5.14
Mtaji wa soko
98.09B
Wastani wa kiasi cha mauzo
69.33M
Kiasi cha mauzo ya hisa
83.88M
Gawio
2.29%
Mgawo wa faida wa kila robo mwaka
HK$ 0.03
Tarehe ya kutojumuisha gawio
29 Ago 2025
Uwiano wa bei ya hisa na mapato kwa kila hisa
33.86
Juu kwa wiki 52
HK$ 7.79
Chini kwa wiki 52
HK$ 4.19
EPS
HK$ 0.16
Hisa za wawekezaji
12.64B
Idadi ya wafanyakazi
elfu 23
Fungua
HK$ 5.40
Juu
HK$ 5.50
Chini
HK$ 5.14
Mtaji wa soko
98.09B
Wastani wa kiasi cha mauzo
69.33M
Kiasi cha mauzo ya hisa
83.88M
Gawio
2.29%
Mgawo wa faida wa kila robo mwaka
HK$ 0.03
Tarehe ya kutojumuisha gawio
29 Ago 2025
Uwiano wa bei ya hisa na mapato kwa kila hisa
33.86
Juu kwa wiki 52
HK$ 7.79
Chini kwa wiki 52
HK$ 4.19
EPS
HK$ 0.16
Hisa za wawekezaji
12.64B
Idadi ya wafanyakazi
elfu 23
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
Wasifu
Sino Biopharmaceutical Limited, shortly SBP Group, is a pharmaceutical conglomerate in China. The Company was listed on the Hong Kong Stock Exchange in 2000 and included in 2013 as a constituent stock of MSCI Global Standard Indices – MSCI China Index, Hang Seng Index in 2018, Hang Seng China Enterprises Index in 2019, and Hang Seng Connect Biotech 50 Index and Hang Seng China 25 Index in 2020. The Group’s principal subsidiaries include: Chia Tai Tianqing Pharmaceutical Group Co. Ltd., Beijing Tide Pharmaceutical Co. Ltd., Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd., Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd., Jiangsu Chia Tai Qingjiang Pharmaceutical Co., Ltd. and invoX Pharma Limited. Its products including biopharmaceutical and chemical medicines are used in a host of therapeutic areas, such as tumors, liver diseases, respiratory system diseases and surgery/analgesia. Wikipedia
Kuhusu Sino Biopharmaceutical Ltd
Afisa Mkuu Mtendaji (CEO)Li Yi
Wafanyakazielfu 22.8
Lilianzishwa2000
Makao makuu-
Sekta-
Ripoti za awaliThamani zote katika CNY
Loading Previous Earnings...
Mapato
Mapato halisi
Thamani zote katika CNY
Sep 2025
Des 2025
Mac 2026
Jun 2026
Mapato
7.13B
7.13B
9.72B
9.72B
Gharama ya bidhaa zilizouzwa
1.31B
1.31B
1.65B
1.65B
Gharama ya mapato
1.31B
1.31B
1.65B
1.65B
Gharama za utafiti na maendeleo
2.93B
2.93B
1.54B
1.54B
Jumla ya gharama za utafiti na maendeleo
-
-
-
-
Gharama za uuzaji, za jumla na za usimamizi
2.80B
2.80B
3.11B
3.11B
Gharama ya uendeshaji
4.38B
4.38B
4.77B
4.77B
Jumla ya gharama za uendeshaji
5.69B
5.69B
6.42B
6.42B
Mapato ya uendeshaji
1.44B
1.44B
3.31B
3.31B
Mapato mengine yasiyo ya uendeshaji
97.99M
97.99M
76.64M
76.64M
EBT ikijumuisha vipengee visivyo vya kawaida
488.22M
488.22M
3.67B
3.67B
EBT bila kujumuisha vipengee visivyo vya kawaida
1.55B
1.55B
3.56B
3.56B
Gharama ya kodi ya mapato
323.77M
323.77M
597.96M
597.96M
Kiwango cha kodi kinachotumika
66.32%
66.32%
16.29%
16.29%
Gharama nyingine za uendeshaji
-1.35B
-1.35B
113.21M
113.21M
Mapato halisi
-522.62M
-522.62M
1.72B
1.72B
Kiwango cha faida halisi
-7.33%
-7.33%
17.66%
17.66%
Mapato kwa kila hisa
-
-
-
-
Mapato ya riba na uwekezaji
196.36M
196.36M
250.06M
250.06M
Gharama ya riba
-77.56M
-77.56M
-84.75M
-84.75M
Jumla ya gharama halisi za riba
118.80M
118.80M
165.31M
165.31M
Gharama za kushuka kwa thamani na za kulipa deni
-
-
-
-
Mapato ya kampuni kabla ya riba, kodi, kushuka thamani na kulipa madeni
1.66B
1.66B
3.57B
3.57B
Faida au hasara kutokana na uuzaji wa vipengee
-5.58M
-5.58M
-
-
Maudhui yaliyotayarishwa kwa AI yanaweza kuwa na makosa. Pata maelezo zaidi
Programu za Google